A Perbellini
Impact in
- Rheumatology top 10%
- Osteoarthritis Treatment and Mechanisms
- Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Fibroblast Growth Factor Research 3
- Retinoids in leukemia and cellular processes 1
-
- Proteoglycans and glycosaminoglycans research 5
- Co-authors
- Danila Coradini (5 shared papers)Cinzia Pellizzaro (5 shared papers)Silvia Cantoni (5 shared papers)Ignazio Scarlata (5 shared papers)Gianni Sava (5 shared papers)Maria Grazia Daidone (4 shared papers)Giuliana Miglierini (2 shared papers)Carlo Ventura (2 shared papers)
- Journals
- Journal of Biological Chemistry (2 papers)International Journal of Cancer (2 papers)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)Anti-Cancer Drugs (1 paper)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
A Perbellini
17 papers receiving 711 citations
Peers
Comparison fields: 5 of 92
- Rheumatology 116
- Cell Biology 136
- Genetics 76
- Biomaterials 91
- Oncology 129
Countries citing papers authored by A Perbellini
This map shows the geographic impact of A Perbellini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Perbellini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Perbellini more than expected).
Fields of papers citing papers by A Perbellini
This network shows the impact of papers produced by A Perbellini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Perbellini. The network helps show where A Perbellini may publish in the future.
Co-authors
The 25 scholars most cited alongside A Perbellini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 129 | |
| 2 | 1999 | 103 | |
| 3 | 1999 | 92 | |
| 4 | 2004 | 76 | |
| 5 | The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion | 1995 | 70 |
| 6 | 2004 | 60 | |
| 7 | Hyaluronic acid versus methylprednisolone intra-articularly injected for treatment of osteoarthritis of the knee | 1991 | 38 |
| 8 | 1995 | 38 | |
| 9 | 2004 | 33 | |
| 10 | 1992 | 29 | |
| 11 | A new model for the study of septic shock. | 1978 | 17 |
| 12 | 1992 | 15 | |
| 13 | 2006 | 15 | |
| 14 | 2002 | 13 | |
| 15 | [Spontaneous reparation of post-traumatic tympanic perforation: an experimental study in rats]. | 1991 | 7 |
| 16 | 1999 | 5 | |
| 17 | 1982 | 4 |
About A Perbellini
A Perbellini is a scholar working on Molecular Biology, Cell Biology, Rheumatology, Organic Chemistry and Surgery, having authored 17 papers that have together received 744 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Fibroblast Growth Factor Research (3 papers), Inflammatory mediators and NSAID effects (2 papers), Click Chemistry and Applications (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Retinoids in leukemia and cellular processes (1 paper). The work is most often cited by research in Rheumatology (116 citations), Cell Biology (136 citations), Genetics (76 citations), Biomaterials (91 citations) and Oncology (129 citations). A Perbellini has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Danila Coradini, Cinzia Pellizzaro, Silvia Cantoni, Ignazio Scarlata, Gianni Sava, Maria Grazia Daidone, Giuliana Miglierini, Carlo Ventura, Margherita Maioli and R Gagliardi. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Cancer, Clinical Cancer Research, Investigational New Drugs and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.